News | November 16, 2022
Cadila recognized for its contribution to leprosy treatment
Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress
Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Subscribe To Our Newsletter & Stay Updated
